Company / Assets per Share
Lexaria Bioscience Corp. Assets per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.26
FY2025
5-year range
$0.26 / $4.42
FY2021-FY2025
Trend
-75.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2016 to $4.42 in FY2021.
Based on SEC 10-K filings.
0.26 in FY2025 with a 10-year CAGR of +28.9%.
Declined from $0.52 to $0.26 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -42.2%
- 5-Year CAGR
- +49.1%
- 10-Year CAGR
- +28.9%
Key checks
Key Insights
- In FY2025, assets per share decreased 75.9% year-over-year.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -75.9% |
| FY2024 | $1.10 | +111.5% |
| FY2023 | $0.52 | -62.1% |
| FY2022 | $1.37 | -69.1% |
| FY2021 | $4.42 | +12213.2% |
| FY2020 | $0.04 | +1.4% |
| FY2019 | $0.04 | -36.5% |
| FY2017 | $0.06 | +331.4% |
| FY2016 | $0.01 | -37.8% |
| FY2015 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026